Author
Listed:
- Travis Satnarine
(Department of Neonatology, Port of Spain General Hospital, Trinidad and Tobago)
- Areeg Ahmed
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Ayesha Haq
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Deepkumar Patel
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Sai Dheeraj Gutlapalli
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Grethel N. Hernandez
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Kofi Seffah
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Mustafa Abrar Zaman
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Nimra Awais
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
- Safeera Khan
(California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534)
Abstract
This paper explores the neuropsychiatric consequences of SARS-CoV-2 (COVID-19) infection, specifically the use of intravenous immunoglobulin (IVIG) therapy in treating central nervous system (CNS) symptoms associated with COVID-19. The authors searched PubMed and Google Scholar using the keywords "IVIG" and "covid-19 neuropsychiatric symptoms" to find five articles, including three case reports, a retrospective study, and a prospective study, that detail the experiences of individuals with persistent neuropsychiatric symptoms after contracting COVID-19. The neuropsychiatric symptoms reported in the analyzed studies include sleep disturbance, exhaustion, cognitive decline, anxiety, and others. Common treatments for post-COVID neuropsychiatric symptoms include medications, cognitive behavioral therapy, and lifestyle modifications. IVIG therapy to manage CNS symptoms of COVID-19 has shown mixed results in studies, with some showing positive effects while others remain inconclusive. Further research is needed to understand this therapy's potential benefits and limitations fully.
Suggested Citation
Travis Satnarine & Areeg Ahmed & Ayesha Haq & Deepkumar Patel & Sai Dheeraj Gutlapalli & Grethel N. Hernandez & Kofi Seffah & Mustafa Abrar Zaman & Nimra Awais & Safeera Khan, 2023.
"Immunotherapy for Post-COVID Neuropsychiatric Symptoms: The Potential of IVIG Treatment,"
Journal of Medical and Health Studies, Al-Kindi Center for Research and Development, vol. 4(2), pages 79-85, March.
Handle:
RePEc:alk:jmhs00:v:4:y:2023:i:2:id:5077
DOI: 10.32996/jmhs.2023.4.2.11
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:alk:jmhs00:v:4:y:2023:i:2:id:5077. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Al-Kindi Center for Research and Development (email available below). General contact details of provider: https://al-kindipublisher.com/index.php/jmhs .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.